<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39116840</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1662-4033</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Aug</Month><Day>08</Day></PubDate></JournalIssue><Title>Obesity facts</Title><ISOAbbreviation>Obes Facts</ISOAbbreviation></Journal><ArticleTitle>Body Mass Index Is Associated with Post-Acute Elevations in Biomarkers of Platelet Activation and Inflammation in Unvaccinated Adults Diagnosed with COVID-19 in the Previous 8 Weeks.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>6</EndPage><MedlinePgn>1-6</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1159/000540343</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Obesity has arisen as a prominent risk factor for COVID-19 severity and long COVID, potentially owed in part to the obesity-induced proinflammatory state. This study aimed to examine relationships among circulating inflammatory biomarkers and body mass index in nonhospitalized adults recently diagnosed with COVID-19.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This analysis included participants who completed a randomized placebo-controlled trial conducted in October 2020-March 2021. Participants (19-53 years) were unvaccinated and enrolled following COVID-19 diagnosis as allowed by CDC return-to-work guidance. Anthropometrics and biomarkers were assessed at study baseline and week four. We examined the associations between body mass index (BMI) and inflammatory biomarkers via multiple regression models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">At study baseline (i.e., the point of enrollment following COVID-19 diagnosis) across all participants (N = 60), a higher BMI was associated with elevations in several inflammatory biomarkers including IL-6 (&#x3b2; = 7.63, 95% CI = 3.54, 11.89, p = 0.0004), ferritin (&#x3b2; = 6.31, 95% CI = 1.97, 10.83, p = 0.0047), high sensitivity C-reactive protein (&#x3b2; = 13.1, 95% CI = 8.03, 18.42, p = &amp;lt; 0.0001), tumor necrosis factor-&#x3b1; (&#x3b2; = 3.23, 95% CI = 0.91, 5.60, p = 0.0069), IL-12p40 (&#x3b2; = 3.69, 95% CI = 0.93, 6.52, p = 0.0094), IL-13 (&#x3b2; = 5.11, 95% CI = 1.00, 9.40, p = 0.0154), and IL-1Ra (&#x3b2; = 7.57, 95% CI = 3.61, 11.70, p = 0.0003). In control group participants (n = 30) after 4 weeks, a higher BMI was associated with elevations in IL-4 (&#x3b2; = 17.8, 95% CI = 0.84, 37.6, p = 0.0397) and sP-selectin (&#x3b2; = 1.16, 95% CI = 0.22, 2.11, p = 0.0182), controlling for baseline and covariates.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Here, BMI was positively associated with circulating biomarkers of platelet activation and inflammation in adults recently diagnosed with COVID-19 after 4 weeks. The shift in post-acute COVID-19 inflammatory biomarkers associated with an increasing BMI noted here shares similarities to biomarkers of LC reported in the literature.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s). Published by S. Karger AG, Basel.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fessler</LastName><ForeName>Samantha N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>College of Health Solutions, Arizona State University, Tempe, Arizona, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>College of Health Solutions, Arizona State University, Tempe, Arizona, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biodesign Institute, Arizona State University, Tempe, Arizona, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Yung</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Biodesign Institute, Arizona State University, Tempe, Arizona, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Life Sciences, Arizona State University, Tempe, Arizona, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnston</LastName><ForeName>Carol S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>College of Health Solutions, Arizona State University, Tempe, Arizona, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016433">News</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Obes Facts</MedlineTA><NlmUniqueID>101469429</NlmUniqueID><ISSNLinking>1662-4025</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Body mass index</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword><Keyword MajorTopicYN="N">Obesity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>9</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>9</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>8</Day><Hour>18</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39116840</ArticleId><ArticleId IdType="doi">10.1159/000540343</ArticleId><ArticleId IdType="pii">000540343</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>